Longboard Pharmaceuticals Correlations

Summary

LBPHDelisted Stock

USD 59.98 0.00 0.00%

The current 90-days correlation between Longboard Pharmaceuticals and Edgewise Therapeutics is 0.01 (i.e., Significant diversification). The correlation of Longboard Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Longboard Pharmaceuticals Correlation With Market

Good diversification

The correlation between Longboard Pharmaceuticals and DJI is -0.14 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Longboard Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Moving together with Longboard Stock

0.87	EPRX	Eupraxia Pharmaceuticals	Pair Corr
0.73	FRTX	Fresh Tracks Therapeutics	Pair Corr

Moving against Longboard Stock

0.92	HRGN	Harvard Apparatus	Pair Corr
0.75	IRD	Opus Genetics, Symbol Change	Pair Corr
0.69	EMMA	Emmaus Life Sciences	Pair Corr
0.68	DWTX	Dogwood Therapeutics, Symbol Change	Pair Corr
0.67	ENSCW	Ensysce Biosciences	Pair Corr
0.65	FNCH	Finch Therapeutics	Pair Corr
0.59	HURA	TuHURA Biosciences Symbol Change	Pair Corr
0.55	CYCCP	Cyclacel Pharmaceuticals	Pair Corr
0.55	ZBIO	Zenas BioPharma, Common	Pair Corr
0.33	EFTR	Effector Therapeutics	Pair Corr
0.33	ELOX	Eloxx Pharmaceuticals	Pair Corr
0.92	PBLA	Panbela Therapeutics	Pair Corr
0.87	KRBP	Kiromic Biopharma	Pair Corr
0.8	OTLC	Oncotelic Therapeutics	Pair Corr
0.77	LADX	LadRx	Pair Corr
0.77	ORGS	Orgenesis	Pair Corr
0.74	ZIVO	Zivo Bioscience	Pair Corr
0.74	PVCT	Provectus Biopharmaceutica	Pair Corr
0.72	NEXI	Neximmune	Pair Corr
0.69	MTVA	MetaVia Symbol Change	Pair Corr
0.62	NAVB	Navidea Biopharmaceutica	Pair Corr
0.61	NWBO	Northwest Biotherapeutics	Pair Corr
0.5	OKUR	OnKure Therapeutics, Symbol Change	Pair Corr
0.48	ABPWW	Abpro Holdings Symbol Change	Pair Corr
0.43	ONCT	Oncternal Therapeutics	Pair Corr

Related Correlations Analysis

	MOLN	MNOV	ANEB	CSBR	CYT	HOWL	EWTX	DBTX	CELC	CCCC
MOLN		-0.2	-0.32	-0.23	0.11	0.47	0.62	0.55	0.09	-0.09	MOLN
MNOV	-0.2		-0.44	0.44	0.5	-0.59	-0.46	-0.49	-0.74	-0.68	MNOV
ANEB	-0.32	-0.44		-0.47	-0.41	0.44	-0.18	-0.12	0.65	0.76	ANEB
CSBR	-0.23	0.44	-0.47		0.58	-0.51	-0.34	-0.53	-0.53	-0.42	CSBR
CYT	0.11	0.5	-0.41	0.58		-0.28	-0.11	-0.39	-0.42	-0.4	CYT
HOWL	0.47	-0.59	0.44	-0.51	-0.28		0.43	0.44	0.74	0.63	HOWL
EWTX	0.62	-0.46	-0.18	-0.34	-0.11	0.43		0.81	0.38	0.17	EWTX
DBTX	0.55	-0.49	-0.12	-0.53	-0.39	0.44	0.81		0.41	0.2	DBTX
CELC	0.09	-0.74	0.65	-0.53	-0.42	0.74	0.38	0.41		0.88	CELC
CCCC	-0.09	-0.68	0.76	-0.42	-0.4	0.63	0.17	0.2	0.88		CCCC
	MOLN	MNOV	ANEB	CSBR	CYT	HOWL	EWTX	DBTX	CELC	CCCC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CCCC	+ 0.88	CELC
DBTX	+ 0.81	EWTX
CCCC	+ 0.76	ANEB
CELC	+ 0.74	HOWL
CELC	+ 0.65	ANEB
CCCC	+ 0.63	HOWL

High negative correlations

CELC	- 0.74	MNOV
CCCC	- 0.68	MNOV
HOWL	- 0.59	MNOV
CELC	- 0.53	CSBR
DBTX	- 0.53	CSBR
HOWL	- 0.51	CSBR

Risk-Adjusted Indicators

There is a big difference between Longboard Stock performing well and Longboard Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Longboard Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MOLN	4.25	0.34	0.06	(0.43)	4.50	(5.72)	9.38	(7.22)	52.92
MNOV	3.85	0.64	0.14	(0.43)	3.49	(5.29)	9.95	(6.44)	61.30
ANEB	4.84	(0.79)	0.00	(1.42)	0.00	0.00	7.59	(11.48)	76.00
CSBR	3.63	0.78	0.18	(1.42)	3.60	(4.15)	7.97	(5.05)	23.94
CYT	2.76	0.60	0.15	(0.40)	2.57	(3.47)	10.00	(5.26)	36.14
HOWL	4.46	(0.43)	0.00	(0.17)	0.00	0.00	8.54	(8.75)	49.02
EWTX	2.59	0.10	0.03	0.11	3.28	(2.65)	6.44	(5.54)	26.07
DBTX	3.74	0.35	0.08	0.27	4.12	(4.38)	7.85	(7.45)	26.09
CELC	2.15	(0.30)	0.00	(0.20)	0.00	0.00	4.20	(5.83)	16.97
CCCC	3.88	(0.67)	0.00	(0.51)	0.00	0.00	9.28	(8.28)	24.60

View Longboard Pharmaceuticals Related Equities

Molecular Partners AG MediciNova Anebulo Pharmaceuticals Champions Oncology Cyteir Therapeutics Werewolf Therapeutics Edgewise Therapeutics Decibel Therapeutics Celcuity LLC C4 Therapeutics Assembly Biosciences NextCure Nuvation Bio Graphite Bio Instil Bio

Risk & Return

Correlation

Longboard Pharmaceuticals Corporate Management

Dewey McLin	VP Affairs	Profile
Nuggehally Srinivas	VP Pharmacometrics	Profile
Jodi Parsons	VP Affairs	Profile
Chadwick MPH	Executive Operations	Profile
Steven JD	Head Counsel	Profile
Randall MD	Executive Officer	Profile
Megan Knight	Head Relations	Profile

Still Interested in Longboard Pharmaceuticals?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC